The US Food and Drug Administration (FDA) has announced it has approved colon cancer drug, Zaltrap, for use in combination with a folinic acid, fluorouracil and iriontecan (FOLFIRI) chemotherapy ...

Sanofi's colorectal cancer treatment Zaltrap has been given a final 'no' from NICE, despite the firm offering a price cut. The cost effectiveness watchdog issued final guidance not to recommend ...